Observational studyBMC pulmonary medicine2025
Application of a diagnostic strategy for patients with suspected pulmonary embolism in a middle-income country.
Observational study in BMC pulmonary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe implementation of diagnostic strategies in patients with suspected pulmonary embolism (PE) aims to reduce lethality and optimize hospital resources. The objectives of the present study were to describe the use of computed tomographic pulmonary angiography (CTPA) in a hospital located in a middle-income country and apply a diagnostic strategy to optimize the use of CTPA in the management of patients with suspected PE, while also evaluating its impact on hospital costs.
methodsRetrospective observational study. All CTPA studies ordered in patients with suspected PE during the study period were reviewed. CTPA requests from hospitalized and emergency department patients for suspected PE were included. Patients treated in outpatient clinics, with hemodynamic instability, incomplete medical history, pregnant women, and those under 18 years old were excluded. The Student’s t-test for paired samples was used to compare CTPA-related costs.
resultsCTPA was performed on 103 patients with suspected PE and 85 patients met the inclusion criteria. The diagnosis of PE was confirmed by CTPA in 13% [n = 11] of patients. Out of the 85 patients included, the diagnostic strategy could not be applied in 14 of them due to the unavailability of D-dimer. We found that the use of the diagnostic strategy would reduce CTPA requests by at least 20% and could significantly decrease hospital costs ($26,746 in all included patients vs. $17,621 with diagnostic strategy, p = 0.01).
conclusionsAmong all patients suspected of PE, 13% were confirmed by CTPA. The use of the diagnostic strategy decreases the percentage of CTPA requests and, consequently, significantly reduce patient irradiation and hospital costs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.